Company profile
ENANTIOS AG
Modern pharmaceutics are becoming more and more structurally complex, and traditional measurement techniques are slowing down the discovery pipeline. At ENANTIOS we are leveraging new measurement technology to accelerate drug development and discovery, and enable more complete quality testing in the manufacturing stage.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
